KDM1A and colorectal carcinoma: Li et al. reported that ZY0511, a KDM1A-specific inhibitor, exerts antiproliferative effects on CRC cells by upregulating the expression of DNA Damage Inducible Transcript 4, a known mTORC1 inhibitor, through altering the H3K4 methylation level at the promoter [96].